TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
TXMD 'in mevcut fiyatı $2.29 'dir, son işlem günde 0% azalmış etti.
TherapeuticsMD Inc için ana iş temaları veya sektörler nelerdir?
TherapeuticsMD Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
TherapeuticsMD Inc 'in piyasa değerlemesi nedir?
TherapeuticsMD Inc 'in mevcut piyasa değerlemesi $26.4M 'dir
TherapeuticsMD Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist TherapeuticsMD Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 1 sat ve 0 güçlü sat içermektedir